NOVEL PHARMA
사이트 메뉴
ABOUT US
SOCIAL RESPONSIBILITY
LEADERSHIP
OUR SCIENCE
TARGET INDICATIONS
DRUG DELIVERY
PIPELINE
INVESTOR & MEDIA
INVESTORS
PRESS RELEASE
CONTACT
CONTACT US
KR
EN
PRESS RELEASE
Date
Title
2022.07.25
Korea reimburses the most costly drug 'Zolgensma'...increasing interest in Novel Pharma, a bio-venture company for rare disease therapeutics
1
2
[ 3 ]
Title
Contents
Name
Search